What we do:
Biomarkers and Personalised Medicine
Client: Ulive Enterprises Ltd on behalf of Liverpool University’s School of Cancer Studies and the Cancer Tissue Bank Research Centre
Ithaka’s role:
- Reviewing internal expertise;
- identifying USP & market needs;
- detailed discussions with internal staff & potential customers
Results:
- Prioritised opportunities & commercial options; development of high level implementation plan
Client: University of Cambridge/ Psynova Neurotech with a research programme in biomarkers for neuropsychiatric disorders such as schizophrenia and bipolar disorder.
Ithaka’s role:
- Ithaka appointed by the Cambridge University Proof of Concept Fund to work with scientific founder Dr Sabine Bahn to develop a business plan.
- Paul Rodgers appointed as Executive Chairman to lead the commercial and fund raising activities.
Results:
Paul has played a significant role in nurturing the Company and in achieving:
- Over £8M of funding secured from investors, a corporate partner and grants from the Innovative Medicines Initiative and the EU Framework 7 programme.
- A corporate deal with Rules-Based Medicine Inc. in 2008 which positioned Psynova to:
- Launch its first product, VeriPsych™, a diagnostic test for schizophrenia, in USA in 2010;
- Secure reimbursement for product in USA;
- A collaboration with a Hoffman-La Roche to develop a companion diagnostic for a novel schizophrenia drug.